Literature DB >> 31999896

Kratom (Mitragyna speciosa): Friend or Foe?

Roopa Sethi1,2,3, Nguyen Hoang3, Dheepthi Arakonam Ravishankar3, Megan McCracken4, Ann M Manzardo3.   

Abstract

Increased use of the opioid-related plant kratom as an alternative treatment for opioid withdrawal symptoms has raised concerns regarding its potential for abuse and severe adverse effects. A review of the literature was performed to characterize kratom's pharmacology, clinical efficacy, and adverse effects to increase understanding and evaluate potential use as an alternative treatment for opioid dependence. Kratom use initiated as self-medication for an opioid use disorder or pain syndrome in the absence of effective alternatives is associated with a risk of kratom dependence, withdrawal, and life-threatening toxicity. The potential for a serious adverse reaction should discourage unregulated use of kratom products. © Copyright 2020 Physicians Postgraduate Press, Inc.

Entities:  

Year:  2020        PMID: 31999896     DOI: 10.4088/PCC.19nr02507

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


  2 in total

1.  Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis".

Authors:  Eric R Braverman; Catherine A Dennen; Mark S Gold; Abdalla Bowirrat; Ashim Gupta; David Baron; A Kenison Roy; David E Smith; Jean Lud Cadet; Kenneth Blum
Journal:  Int J Environ Res Public Health       Date:  2022-04-30       Impact factor: 4.614

2.  Current and Future Potential Impact of COVID-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use.

Authors:  Darshan Singh; Paula N Brown; Eduardo Cinosi; Ornella Corazza; Jack E Henningfield; Albert Garcia-Romeu; Christopher R McCurdy; Lance R McMahon; Walter C Prozialeck; Kirsten E Smith; Marc T Swogger; Charles Veltri; Zach Walsh; Oliver Grundmann
Journal:  Front Psychiatry       Date:  2020-11-26       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.